fluorodeoxyglucose f18 has been researched along with Argentaffinoma in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.20) | 18.2507 |
2000's | 34 (37.36) | 29.6817 |
2010's | 48 (52.75) | 24.3611 |
2020's | 7 (7.69) | 2.80 |
Authors | Studies |
---|---|
Ikeda, H; Kanamori, T; Kometani, M; Nakano, Y; Nomura, C; Shima, KR; Takamura, T; Takeshita, Y; Tanaka, T; Yoneda, T | 1 |
Abenavoli, EM; Antonuzzo, L; Berti, V; Briganti, V; Danti, G; Grosso, AM; Lavacchi, D; Linguanti, F; Matteini, M; Miele, V; Mini, E; Mungai, F; Novelli, L; Sciagrà, R; Vaggelli, L | 1 |
Clini, E; Facciolongo, N; Marchioni, A; Musci, G; Piro, R; Taddei, S; Tonelli, R | 1 |
Auernhammer, CJ; Cyran, C; Ricke, J; Todica, A; Winter, KS | 1 |
Gluskin, JS; Montane, G; Nanni, G; Perez, R | 1 |
Chen, Y; Liu, H; Liu, L | 1 |
Chatterjee, D; Das, CK; Krishnaraju, VS; Mittal, BR; Satapathy, S; Shukla, J; Sood, A | 1 |
Wang, H; Zhao, J | 1 |
Aghayeva, G; Akhan, O; Akıncı, D; Arslan, S; Çiftçi, T; Önder, S; Sarıkaya, Y; Ünal, E | 1 |
McClenathan, M; Peacock, JG | 1 |
Prosch, H | 1 |
Alifano, M; Charpentier, MC; Cusumano, G; Damotte, D; Fournel, L; Galia, A; Nicolosi, M; Regnard, JF; Strano, S; Terminella, A | 1 |
González-Santoni, R; Gurrea-Rosas, C; Maldonado-Vargas, JA; McBurney-Henriquez, E; Montalvo-Fitzpatrick, J; Saadé-Yordán, C | 1 |
Maki, Y; Nakata, K; Nishimura, R; Sugawara, Y; Sugimoto, R; Teramoto, N; Ueno, T; Yamashita, M | 1 |
Hashimoto, H; Kameda, K; Ozeki, Y; Taguchi, S | 1 |
Gawde, S; Kasat, A; Parekh, S; Ramaswamy, V; Singhal, A | 1 |
Coruzzi, C; Di Stefano, T; Filice, A; Lococo, F; Mengoli, MC; Paci, M; Rapicetta, C; Versari, A | 1 |
Cheng, W; Hou, G; Jiang, Y | 1 |
Billè, A; Girelli, L; Leo, F; Pastorino, U | 1 |
Benveniste, MF; Fox, PS; Marom, EM; Mawlawi, O; Moran, CA; Munden, RF; Swisher, SG | 1 |
Baram, D; Bilfinger, TV; Bishawi, M; Freiberg, E; Halbreiner, MS; Matthews, R; Moore, W | 1 |
Hosokawa, K; Kajihara, M; Nishimura, R; Ohtani, H; Sakai, S; Sawada, S; Shimizu, T; Sugawara, Y; Takahashi, T; Tanabe, Y; Yamashita, M | 1 |
Warner, RR; Zanzi, I | 1 |
Petrun'kin, AM; Tlostanova, MS | 1 |
Horton, MP; Hunt, BM; Vallières, E | 1 |
Gómez-Rio, M; Jiménez-Heffernan, A; Llamas-Elvira, JM; Ramos-Font, C; Rodríguez-Fernández, A; Sánchez Sánchez, R | 1 |
Horikawa, M; Kaji, T; Miyai, K; Shinmoto, H; Soga, S | 1 |
Aramini, B; Casali, C; Casolo, A; Franceschetto, A; Kaleci, S; Massi, L; Morandi, U; Nesci, J; Proli, C; Stefani, A | 1 |
Karunanithi, S; Khilnani, GC; Kumar, A; Kumar, R; Venkitaraman, B | 1 |
Alifano, M; Cavazza, A; Cesario, A; Filice, A; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Sgarbi, G; Treglia, G; Versari, A | 1 |
Santhanam, P; Taïeb, D | 1 |
Ariyaratnam, P; Beddow, E; Darr, A; Dusmet, M; Granato, F; Greenwood, A; Iyer, S; Kirk, A; Leung, M; Lim, E; Loubani, M; Marchbank, A; Mohamed, S; Naidu, B; Nicholson, AG; Pattenden, HA; Shackcloth, M; West, D | 1 |
Cardillo, G; De Waure, C; Filice, A; Giordano, A; Granone, P; Graziano, P; Lococo, F; Perotti, G; Rindi, G; Rossi, G; Rufini, V; Sgarbi, G; Stefanelli, A; Versari, A | 1 |
Acevedo-Báñez, I; García-Gómez, FJ; Mangas-Cruz, MA; Muñiz-Grijalvo, O; Tirado-Hospital, JL | 1 |
Brambilla, D; Fazio, N; Galetta, D; Gasparri, R; Maisonneuve, P; Paganelli, G; Petrella, F; Rezende, GC; Spaggiari, L; Travaini, LL | 1 |
Axelsson, R; Dobra, K; Grundberg, O; Jacobsson, H; Kölbeck, KG; Sánchez-Crespo, A; Sundin, A; Uhlén, N | 1 |
Doherty, C; Muzaffar, R; Osman, MM; Parkar, ND; Raslan, OA | 1 |
Axelsson, R; Sundin, A; Uhlén, N | 1 |
Lococo, F; Rufini, V; Treglia, G | 1 |
Boyum, RD; Dalane, SS; Kelly, W; Peterson, PG; Warren, BD; Warren, WA | 1 |
Hsu, J; Jia, L; Keshavamurthy, J; Pucar, D; Williams, H | 1 |
Caplin, ME; Karpathakis, A; Lumgair, H; Marelli, L; Pericleous, M; Reiner, J; Thirlwell, C; Toumpanakis, C | 1 |
Aye, RW; Brown, LM; Cattoni, M; Costas, K; Farivar, AS; Farjah, F; Hubka, M; Imperatori, A; Kaplan, S; Louie, BE; Mann, C; Margaritora, S; Rotolo, N; Sarkeshik, AA; Siciliani, A; Vallières, E; Wandell, G | 1 |
Brouwers, AH; de Vries, EG; Fiebrich, HB; Links, TP | 1 |
Abe, T; Amemiya, R; Asato, Y; Iijima, T; Kiyoshima, M; Nagai, H; Okumura, T; Saito, H; Sato, M; Shioyama, Y | 1 |
Deroose, CM; Himpe, U; Leyn, PD; Vansteenkiste, J; Verbeken, E | 1 |
Bouchard, P; Duron, F; Grangé, JD; Houry, S; Huchet, V; Kerrou, K; Lotz, JP; Montravers, F; Nataf, V; Rougier, P; Ruszniewski, P; Talbot, JN | 1 |
Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP | 1 |
Li, B; Ning, G; Xu, H; Zhai, G; Zhang, M | 1 |
Irei, T; Kobashi, Y; Mouri, K; Oka, M; Shimizu, H | 1 |
Choi, BW; Kim, HW; Won, KS; Zeon, SK | 1 |
Hirata, Y; Hirooka, S; Izumiyama, H; Sugiyama, T; Tani, Y | 1 |
Aoki, M; Hashimoto, K; Nakanishi, T; Otake, Y | 1 |
Araki, K; Kadowaki, T; Morioka, N; Tokushima, T; Yano, S | 1 |
Bücker, A; Grgic, A; Hellwig, D; Khreish, F; Kirsch, CM; Mathews, J | 1 |
Argibay, S; Cabezas-Agrícola, JM; Cameselle-Teijeiro, JM; Casanueva, F; Prieto-Tenreiro, A | 1 |
Dutta, R; Jindal, T; Kumar, A; Kumar, R; Malhotra, A; Meena, M; Venkitaraman, B | 1 |
Burger, D; Csanadi, A; Keck, T; Laubner, K; Lausch, M; Meyer, PT; Perakakis, N; Seufert, J; Steffl, D | 1 |
Gurel, D; Kargi, A; Onen, A; Ozdogan, O; Sevinc, C; Turan, O | 1 |
Cheng, MF; Lin, MW; Shih, SR; Tzen, KY; Wu, CT; Wu, YW; Yen, RF | 1 |
Abolmaali, N; Bornstein, SR; Därr, R; Eisenhofer, G; Gastmeier, J; Hofbauer, LC; Jelinek, V; Kamvissi, V; Wieczorek, K; Zöphel, K | 1 |
Adalet, I; Kuyumcu, S; Ozkan, ZG; Sanli, Y; Turkmen, C; Yilmazbayhan, D | 1 |
Fukui, T; Fukumoto, K; Ishikawa, Y; Kato, K; Kawaguchi, K; Matsuo, K; Taniguchi, T; Yokoi, K | 1 |
Belhocine, T; Foidart, J; Hustinx, R; Najjar, F; Quatresooz, P; Rigo, P; Thiry, A | 1 |
Bauditz, J; Biering, H; Gerl, H; Lochs, H; Pirlich, M; Sandrock, D | 1 |
Bingham, JB; Clarke, SE; Groves, AM; Hain, SF; Mohan, HK; Wegner, EA | 1 |
Aksoy, E; Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Mühling, B; Neumaier, B; Nüssle-Kügele, K; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L | 1 |
Jain, M; Katz, DS; Trow, T; Yung, E | 1 |
Akhurst, T; Bains, MS; Downey, RJ; Gonen, M; Larson, S; Rusch, V; Vincent, A | 1 |
Alberini, JL; Corone, C; Dartevelle, P; De Montpreville, V; Leroy-Ladurie, F; Nguyen, C; Pecking, AP; Wartski, M | 1 |
Eriksson, B; Oberg, K | 1 |
Bomanji, JB; Conway, GS; Datta, SN; Kaya, B; Manning, P; Markou, A | 1 |
Nguyen, BD; Ram, PC | 1 |
Avram, AM; Kalemkerian, GP; Mackie, GC; Schneider, BJ; Shulkin, BL | 1 |
Bryant, AS; Cerfolio, RJ | 1 |
de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; van der Horst-Schrivers, AN | 1 |
Blumstein, NM; Buck, AK; Hombach, V; Kropf, C; Krüger, S; Mottaghy, FM; Pauls, S; Reske, SN; Schelzig, H; Schumann, C | 1 |
Ames, ED; Bhargava, P; Brown, J; Kang, P; Shin, V | 1 |
Allen, MS; Aubry, MC; Daniels, CE; Jett, JR; Lowe, VJ | 1 |
Kim, EE; Ng, CS; Tamm, EP | 1 |
Fujishita, M; Fujishita, T; Kishida, M; Kobayashi, M; Maruyama, M; Miyabayashi, K; Mizushima, Y; Shinoda, C; Taki, H | 1 |
Broussolle, C; Collardeau-Frachon, S; De La Roche, E; Gomard-Mennesson, E; Lombard-Bohas, C; Sève, P | 1 |
Brouwers, AH; de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; Vanghillewe, K | 1 |
Ichinose, Y; Maruyama, R; Nishiyama, K; Okamoto, T; Seto, T; Suemitsu, R; Wataya, H | 1 |
Carneiro, MP; Domingues, RC; Gadelha, MR; Madi, K; Moraes, AB; Neto, LV; Taboada, GF; Wildemberg, LE | 1 |
Jadvar, H; Segall, GM | 1 |
Ahuja, V; Coleman, RE; Erasmus, JJ; Goodman, PC; McAdams, HP; Patz, EF | 1 |
Donckier, JE; Pochet, JM; Roelants, V | 1 |
Bomanji, JB; Costa, DC; Ell, PJ; Le Rest, C; Townsend, CE; Visvikis, D | 1 |
Altehoefer, C; Ghanem, N; Hoegerle, S; Koehler, G; Moser, E; Nitzsche, E; Scheruebl, H; Waller, CF | 1 |
Angelberger, P; Dudczak, R; Füger, B; Kletter, K; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Patri, P; Raderer, M; Traub, T; Virgolini, I; Wogritsch, S | 1 |
9 review(s) available for fluorodeoxyglucose f18 and Argentaffinoma
Article | Year |
---|---|
[Pulmonary carcinoids and carcinoids of the small intestine].
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
Rare Pulmonary Tumors and Carcinoma Mimickers; Experience from an Interventional Radiology Unit with Radiologic-pathologic Correlation- A Pictoral Essay.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiology, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.
Topics: Acetates; Carcinoid Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.
Topics: Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients.
Topics: Antineoplastic Agents; Bronchial Neoplasms; Carcinoid Tumor; Chromogranin A; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Mortality; Neoplasm Staging; Neuroendocrine Tumors; Outcome Assessment, Health Care; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2018 |
PET scan in occult ectopic ACTH syndrome: a useful tool?
Topics: ACTH Syndrome, Ectopic; Adult; Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Male; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin | 2005 |
Imaging of neuroendocrine tumors.
Topics: Carcinoid Tumor; Carcinoma, Neuroendocrine; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Paraganglioma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
82 other study(ies) available for fluorodeoxyglucose f18 and Argentaffinoma
Article | Year |
---|---|
Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome.
Topics: ACTH Syndrome, Ectopic; Aged; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin | 2022 |
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cell Proliferation; Fluorodeoxyglucose F18; Glycolysis; Humans; Ki-67 Antigen; Lung; Lung Neoplasms; Middle Aged; Molecular Imaging; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Tumor Burden | 2023 |
Atypical diagnosis for typical lung carcinoid.
Topics: Aged; Bronchoscopy; Carcinoid Tumor; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule | 2019 |
PET-CT for Evaluating Breast Cancer Yields Incidental Finding in the Lung.
Topics: Aged; Biopsy; Breast Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymphatic Metastasis; Mammography; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Thymic carcinoid mimicking mediastinal lymphoma on
Topics: Adult; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thymus Neoplasms | 2021 |
Expression of CXCR4 Receptors in Refractory Atypical Mediastinal Carcinoid.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Mediastinal Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Receptors, CXCR4; Receptors, Somatostatin | 2020 |
Differential diagnostic value of
Topics: Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Hamartoma; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
The "Ultimate Triple PET": 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer.
Topics: Aged; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radionuclide Imaging | 2022 |
[Pulmonary carcinoid tumors].
Topics: Aged; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
Topics: Adult; Aged; Carcinoid Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 2017 |
Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
Topics: Aged; Asymptomatic Diseases; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Surgical outcomes in 13 patients with bronchopulmonary carcinoid tumors including one recurrent oncocytic carcinoid tumor.
Topics: Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
[Typical Carcinoid of the Lung with Abnormal Elevation of Serum Pro-gastrin-releasing Peptide (ProGRP)].
Topics: Adult; Biomarkers, Tumor; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Case of Solitary Peritoneal Metastasis From Atypical Bronchopulmonary Carcinoid on 18F-FDG PET/CT.
Topics: Adult; Biopsy, Fine-Needle; Bronchi; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Diagnostic performances of 68Ga-DOTATOC versus 18Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumours and interrelationship with histological features.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Neoplasms; Male; Octreotide; Organometallic Compounds; Pneumonectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2019 |
A false positive fluorodeoxyglucose lymphadenopathy in a patient with pulmonary carcinoid tumor and previous breast reconstruction after bilateral mastectomy.
Topics: Biopsy; Breast Neoplasms; Carcinoid Tumor; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Lymphatic Diseases; Mammaplasty; Mastectomy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Silicone Gels; Tomography, X-Ray Computed | 2014 |
FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
FDG-PET imaging in patients with pulmonary carcinoid tumor.
Topics: Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Solitary Pulmonary Nodule | 2013 |
Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
Topics: Aged; Biological Transport; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Observations on the effects of lithium on carcinoid tumors.
Topics: Bone Neoplasms; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lithium Compounds; Liver Neoplasms; Male; Mood Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2013 |
[Sensitivity of PET with 18F-fluorodesoxyglucose in the diagnosis of neuroendocrine tumors of the lungs].
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2013 |
Bronchogenic carcinoid tumours that are 18F-fluorodeoxyglucose avid on positron emission tomography.
Topics: Carcinoid Tumor; Carcinoma, Bronchogenic; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2014 |
Ability of FDG-PET/CT in the detection of gallbladder cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT and MR findings of ovarian carcinoid within a dermoid cyst.
Topics: Carcinoid Tumor; Dermoid Cyst; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Mixed Tumor, Malignant; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.
Topics: Adult; Aged; Bronchial Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
Topics: Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor.
Topics: ACTH Syndrome, Ectopic; Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pituitary ACTH Hypersecretion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2015 |
Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Topics: Adult; Carcinoid Tumor; Carcinoma, Neuroendocrine; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Case 227: Endobronchial Carcinoid Tumor with Incidental Metastatic Breast Cancer Detected with Somatostatin Receptor Scintigraphy ((111)In Pentreotide).
Topics: Adult; Biopsy; Breast Neoplasms; Bronchial Neoplasms; Bronchoscopy; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, X-Ray Computed | 2016 |
18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Hamartoma; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Re: 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Hamartoma; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Ten Years of Chronic Cough in a 64-Year-Old Man With Multiple Pulmonary Nodules.
Topics: Carcinoid Tumor; Chronic Disease; Cough; Dyspnea; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Residual Volume; Time Factors; Tomography, X-Ray Computed; Total Lung Capacity; Vital Capacity | 2016 |
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Granulomatous Inflammation Mimicking High-Grade Malignancy on FDG-PET/CT.
Topics: Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung; Lung Neoplasms; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Images in cardiovascular medicine: myocardial metastases of carcinoid visualized by 18F-dihydroxy-phenyl-alanine positron emission tomography.
Topics: Carcinoid Heart Disease; Carcinoid Tumor; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
FDG PET/CT findings of thymic carcinoid and bronchial carcinoid in a patient with multiple neuroendocrine neoplasia type1.
Topics: Adult; Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphatic Metastasis; Male; Multiple Endocrine Neoplasia Type 1; Positron-Emission Tomography; Proto-Oncogene Proteins; Sensitivity and Specificity; Thymus Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
Topics: Bronchial Neoplasms; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Neoplasms; Male; Metaplasia; Middle Aged; Neoplasms, Second Primary; Ossification, Heterotopic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.
Topics: Adult; Biopsy; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ileal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography | 2009 |
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2009 |
The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors.
Topics: ACTH Syndrome, Ectopic; ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Male; Middle Aged; Positron-Emission Tomography; Tomography, Emission-Computed | 2009 |
Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years.
Topics: Aged, 80 and over; Biopsy; Bone Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thymus Neoplasms; Time Factors | 2009 |
Cervical tuberculous lymphadenitis mimicking distant lymph node metastasis on F-18 FDG PET/CT in a patient with gastric carcinoid tumor.
Topics: Adult; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2009 |
Ectopic ACTH syndrome caused by bronchial carcinoid tumor indistinguishable from Cushing's disease.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Aged; Bronchial Neoplasms; Carcinoid Tumor; Corticotropin-Releasing Hormone; Diabetes Mellitus; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Hypertension; Octreotide; Pituitary ACTH Hypersecretion; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Tomography, X-Ray Computed | 2010 |
Atypical carcinoid of thymus associated with multiple endocrine neoplasia syndrome type 1.
Topics: Brachiocephalic Veins; Carcinoid Tumor; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Mutation; Pneumonectomy; Positron-Emission Tomography; Proto-Oncogene Proteins; Radiopharmaceuticals; Thymectomy; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
A case of pulmonary typical carcinoid with an extensive oncocytic component showing intense uptake of FDG.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Simultaneous occurrence of typical carcinoid and non-small-cell lung cancer in the same lung lobe: value of nuclear medicine.
Topics: Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography | 2011 |
[The value of 18FDG-PET for localization of ectopic Cushing's syndrome due to occult bronchial carcinoid].
Topics: Adult; Bronchial Neoplasms; Carcinoid Tumor; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.
Topics: Adolescent; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Middle Aged; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Ectopic ACTH-syndrome due to a neuroendocrine tumour of the appendix.
Topics: ACTH Syndrome, Ectopic; Adult; Appendiceal Neoplasms; Carcinoid Tumor; Combined Modality Therapy; Cushing Syndrome; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2011 |
Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Topics: Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Asymmetric intense bilateral adrenal uptake on [18F]fluorodeoxyglucose positron emission tomography/computed tomography in a patient with solitary pulmonary nodule.
Topics: Adrenal Glands; Aged; Bronchial Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2012 |
Combined use of 68Ga-DOTATATE and 18F-FDG PET/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome.
Topics: ACTH Syndrome, Ectopic; Aged; Carcinoid Tumor; Carcinoma, Bronchogenic; Drug Combinations; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Organometallic Compounds; Pituitary ACTH Hypersecretion; Radionuclide Imaging | 2012 |
Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Octreotide; Positron-Emission Tomography; Prognosis; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2012 |
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoid Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Statistics as Topic; Tumor Suppressor Protein p53 | 2002 |
Positron emission tomography with FDG to show thymic carcinoid.
Topics: Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Thymus Neoplasms; Tomography, Emission-Computed | 2004 |
Lymph node staging in lung cancer using [18F]FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoid Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
F-18 FDG positron emission tomography demonstration of pulmonary carcinoid.
Topics: Aged; Breast Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
Topics: Adult; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed | 2004 |
Typical and atypical bronchopulmonary carcinoid tumors on FDG PET/CT imaging.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Carcinoid Tumor; Corticotropin-Releasing Hormone; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Paraneoplastic Endocrine Syndromes; Positron-Emission Tomography; Recurrence; Thymectomy; Thymus Neoplasms | 2005 |
Bronchopulmonary carcinoid tumor and related cervical vertebral metastasis with PET-positive and octreotide-negative scintigraphy.
Topics: Aged; Bronchial Neoplasms; Carcinoid Tumor; Cervical Vertebrae; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms | 2006 |
Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Topics: Adult; Bronchial Neoplasms; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Radiopharmaceuticals; Sarcoidosis; Somatostatin; Tomography, Emission-Computed | 2006 |
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lung Diseases; Lung Diseases, Fungal; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2006 |
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Somatostatin; Tomography, X-Ray Computed | 2006 |
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Topics: Adult; Aged; Carcinoid Tumor; Cell Division; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2007 |
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Topics: Adult; Aged; Biopsy; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule | 2007 |
Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
Topics: 3-Iodobenzylguanidine; Aged; Bone Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thymus Neoplasms | 2007 |
[Thymic carcinoid tumor revealed by a Cushing's syndrome: usefulness of positron emission tomography].
Topics: Carcinoid Tumor; Cushing Syndrome; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thymus Neoplasms | 2008 |
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Adult; Aged; Carbon Radioisotopes; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Pulmonary typical carcinoid tumor and liver metastasis with hypermetabolism on 18-fluorodeoxyglucose PET: a case report.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2008 |
Utility of [(18)F] fluoro-2-deoxy-D: -glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors.
Topics: Adult; Carcinoid Tumor; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Positron-Emission Tomography | 2009 |
False-negative fluorine-18-FDG PET in metastatic carcinoid.
Topics: Carcinoid Tumor; Deoxyglucose; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Topics: Adult; Aged; Biopsy; Carcinoid Tumor; Diagnosis, Differential; Disease-Free Survival; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Staging of non-small-cell lung cancer with positron-emission tomography.
Topics: Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Functional imaging of malignant paragangliomas and carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Paraganglioma; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Topics: Adenocarcinoma; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Intestinal Neoplasms; Ligands; Lung Neoplasms; Lymphoma; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tyrosine | 2001 |